Though there is no consensus on the role of CXCR4 in AALD fibrosis, there are studies showing that the blockading of CXCR4 signaling suppresses HSC activation and proliferation, leading to a downregulation of collagen I and α-SMA expression in liver fibrosis [22,23]. Here, ACTA1 is linked to Hepatic fibrosis.